Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


Articles published in Am J Manag Care

Retrieve available abstracts of 58 articles:
HTML format



Single Articles


    March 2021
  1. LANDON BE, Zaslavsky AM, Souza J, Ayanian JZ, et al
    Use of diabetes medications in traditional Medicare and Medicare Advantage.
    Am J Manag Care. 2021;27:e80-e88.
    PubMed     Abstract available


  2. LISS DT, Kang RH, Lancki N, O'Brien MJ, et al
    Costs for commercially insured adults prescribed second-line diabetes medications.
    Am J Manag Care. 2021;27:e72-e79.
    PubMed     Abstract available


  3. AHERN DK, Aberger EW, Wroblewski JP, Zheng Q, et al
    Behavior-based diabetes management: impact on care, hospitalizations, and costs.
    Am J Manag Care. 2021;27:96-102.
    PubMed     Abstract available


    December 2020
  4. SCHNEIDER D, Taddei-Allen P, Dougherty T
    The importance of patient-reported outcomes in type 2 diabetes: insight from the PIONEER program with oral semaglutide.
    Am J Manag Care. 2020;26.
    PubMed     Abstract available


  5. DOUGHERTY T, Heile M
    Type 2 diabetes in the US managed care setting: the burden of disease and rationale for an oral glucagon-like peptide-1 receptor agonist.
    Am J Manag Care. 2020;26.
    PubMed     Abstract available


  6. HEILE M, Taddei-Allen P
    The evidence for oral semaglutide in type 2 diabetes from a managed care perspective.
    Am J Manag Care. 2020;26.
    PubMed    


    November 2020
  7. CLEMENTS JM, Ragina NP, Killingsworth J, Weiss TG, et al
    Differences in spending for diabetes and multiple chronic conditions in Michigan Medicare beneficiaries.
    Am J Manag Care. 2020;26:e362-e368.
    PubMed     Abstract available


    August 2020
  8. CHEN YC, Cheng SH, Chen CC
    Keeping up with guideline recommendations: does patient volume matter in diabetes care?
    Am J Manag Care. 2020;26:e264-e271.
    PubMed     Abstract available


    June 2020
  9. RITCHIE ND, Sauder KA, Gritz RM
    Medicare Diabetes Prevention Program: where are the suppliers?
    Am J Manag Care. 2020;26:e198-e201.
    PubMed     Abstract available


    April 2020
  10. AKIROV A, Shochat T, Shimon I
    Solid-organ transplant recipients with hyperglycemia on admission face worse outcomes.
    Am J Manag Care. 2020;26:163-168.
    PubMed     Abstract available


    March 2020
  11. HUNG A, Jois B, Lugo A, Slejko JF, et al
    Cost-effectiveness of diabetes treatment sequences to inform step therapy policies.
    Am J Manag Care. 2020;26:e76-e83.
    PubMed     Abstract available


  12. MOREFIELD B, Tomai L, Slanchev V, Klemes A, et al
    Payer effects of personalized preventive care for patients with diabetes.
    Am J Manag Care. 2020;26:e70-e75.
    PubMed     Abstract available


    October 2019
  13. CONEY JM
    Addressing unmet needs in diabetic retinopathy.
    Am J Manag Care. 2019;25.
    PubMed     Abstract available


    September 2019
  14. ROSENBERG J
    As a child, diabetes was hard to accept. Now, she's living with the complications.
    Am J Manag Care. 2019;25.
    PubMed    


  15. ROSENBERG J
    For young adults with type 1 diabetes, insulin costs can mean chasing benefits, not dreams.
    Am J Manag Care. 2019;25.
    PubMed    


  16. PARK K, Jeong AE, Guenther-Gleason E, Jain SH, et al
    Impact of switching analogue insulin to human insulin in diabetes.
    Am J Manag Care. 2019;25.
    PubMed    


    July 2019
  17. DAVIS J, Lim E, Taira DA, Chen J, et al
    Healthcare network analysis of patients with diabetes and their physicians.
    Am J Manag Care. 2019;25:e192-e197.
    PubMed     Abstract available


    May 2019
  18. PAWASKAR M, Bilir SP, Kowal S, Gonzalez C, et al
    Cost-effectiveness of DPP-4 inhibitor and SGLT2 inhibitor combination therapy for type 2 diabetes.
    Am J Manag Care. 2019;25:231-238.
    PubMed     Abstract available


    March 2019
  19. KOMPALA T, Neinstein A
    A new era: increasing continuous glucose monitoring use in type 2 diabetes.
    Am J Manag Care. 2019;25.
    PubMed    


  20. CAFFREY M, DiGrande S
    Three years after advocates report flaws, Medicare diabetes test strip bidding program nears collapse.
    Am J Manag Care. 2019;25.
    PubMed    


    February 2019
  21. WICKE FS, Glushan A, Schubert I, Koster I, et al
    Performance of the adapted Diabetes Complications Severity Index translated to ICD-10.
    Am J Manag Care. 2019;25:e45-e49.
    PubMed     Abstract available


    December 2018
  22. KIRSNER RS
    Clinical evidence for and cost-effectiveness of advanced cellular tissue products for the treatment of diabetic foot ulcers.
    Am J Manag Care. 2018;24.
    PubMed    


  23. GABBAY R
    A paradigm shift highlights the need to reduce CV risk in diabetes.
    Am J Manag Care. 2018;24.
    PubMed    


    October 2018
  24. PANATTONI L, Chan A, Yang Y, Olson C, et al
    Nudging physicians and patients with autopend clinical decision support to improve diabetes management.
    Am J Manag Care. 2018;24:479-483.
    PubMed     Abstract available


  25. PARSONS AS, Raman V, Starr B, Zezza M, et al
    Medicare underpayment for Diabetes Prevention Program: implications for DPP suppliers.
    Am J Manag Care. 2018;24:475-478.
    PubMed     Abstract available


  26. MUNDT MP, Zakletskaia LI
    Putting the pieces together: EHR communication and diabetes patient outcomes.
    Am J Manag Care. 2018;24:462-468.
    PubMed     Abstract available


    September 2018
  27. FERNANDEZ A, Warton EM, Schillinger D, Moffet HH, et al
    Language barriers and LDL-C/SBP control among Latinos with diabetes.
    Am J Manag Care. 2018;24:405-410.
    PubMed     Abstract available


  28. WARSHAW HS
    Is it time to remodel diabetes self-management education and support?
    Am J Manag Care. 2018;24.
    PubMed    


  29. GABBAY RA
    In the era of payment reform, diabetes educators can lead the way toward value-based care.
    Am J Manag Care. 2018;24.
    PubMed    


    August 2018
  30. MCADAM-MARX C
    Economic implications with newer agents to reduce cardiovascular risk in diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


  31. HUDSPETH B
    The burden of cardiovascular disease in patients with diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


    July 2018
  32. KARIMOVA K, Uhlmann L, Hammer M, Guethlin C, et al
    The development of diabetes complications in GP-centered healthcare.
    Am J Manag Care. 2018;24:322-327.
    PubMed     Abstract available


  33. ALEMAYEHU B, Speiser J, Bloudek L, Sarnes E, et al
    Costs associated with long-acting insulin analogues in patients with diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


    June 2018
  34. GANDA OP, Segal A, Blair E, Beaser R, et al
    CHAPTER 5. Clinical guideline for pharmacological management of adults with type 2 diabetes.
    Am J Manag Care. 2018;24.
    PubMed    


  35. MUNSHI M, Blair E, Ganda OP, Gabbay RA, et al
    CHAPTER 4. Guideline for the care of the older adult with diabetes.
    Am J Manag Care. 2018;24.
    PubMed    


  36. BROWN FM, Anderson-Haynes SE, Blair E, Serdy S, et al
    CHAPTER 3. Guideline for detection and management of diabetes in pregnancy.
    Am J Manag Care. 2018;24.
    PubMed    


  37. HAMDY O, Ganda OP, Maryniuk M, Gabbay RA, et al
    CHAPTER 2. Clinical nutrition guideline for overweight and obese adults with type 2 diabetes (T2D) or prediabetes, or those at high risk for developing T2D.
    Am J Manag Care. 2018;24.
    PubMed    


  38. HAFIDA S, Ganda OP, Gabbay RA
    CHAPTER 1. Clinical guideline for adults with diabetes.
    Am J Manag Care. 2018;24.
    PubMed    


  39. GANDA OP, Gabbay RA
    Joslin Diabetes Center Clinical Oversight Committee.
    Am J Manag Care. 2018;24.
    PubMed    


  40. GANDA OP, Gabbay RA
    From the editors: bringing the Joslin Clinical Guidelines to the diabetes care community.
    Am J Manag Care. 2018;24.
    PubMed    


    May 2018
  41. STUART BC, Slejko JF, Rueda JD, Cooke C, et al
    Impact of formulary restrictions on medication intensification in diabetes treatment.
    Am J Manag Care. 2018;24:239-246.
    PubMed     Abstract available


    April 2018
  42. KORNELIUS E, Yang YS, Lo SC, Peng CH, et al
    Progress of diabetes severity associated with severe hypoglycemia in Taiwan.
    Am J Manag Care. 2018;24:e99-e106.
    PubMed     Abstract available


  43. WITTBRODT ET, Eudicone JM, Farahbakhshian S, McAdam-Marx C, et al
    Comparison of low-dose liraglutide use versus other GLP-1 receptor agonists in patients without type 2 diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


  44. WITTBRODT ET, Eudicone JM, Bell KF, Enhoffer DM, et al
    Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


  45. WITTBRODT ET, Eudicone JM, Bell KF, Enhoffer DM, et al
    Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


  46. HUANG H, Bell KF, Gani R, Tugwell CW, et al
    A retrospective real-world study of dapagliflozin versus other oral antidiabetic drugs added to metformin in patients with type 2 diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


    March 2018
  47. GONZALVO JD
    Introduction to basal insulin therapy: clinical management of diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


  48. ANEESE NJ, Halalau A, Muench S, Shelden D, et al
    Impact of a pharmacist-managed diabetes clinic on quality measures.
    Am J Manag Care. 2018;24.
    PubMed    


  49. SHEERAN D
    How technology can make CMS' Diabetes Prevention Program viable.
    Am J Manag Care. 2018;24.
    PubMed    


  50. WALKER AF, Hall JM, Shenkman EA, Gurka MJ, et al
    Geographic access to endocrinologists for Florida's publicly insured children with diabetes.
    Am J Manag Care. 2018;24.
    PubMed    


    February 2018
  51. AGIRO A, Xie Y, Bowman K, DeVries A, et al
    Leveraging benefit design for better diabetes self-management and A1C control.
    Am J Manag Care. 2018;24:e30-e36.
    PubMed     Abstract available


    January 2018
  52. GRAETZ I, Huang J, Brand RJ, Hsu J, et al
    Bridging the digital divide: mobile access to personal health records among patients with diabetes.
    Am J Manag Care. 2018;24:43-48.
    PubMed     Abstract available


    December 2017
  53. GABBAY RA
    For those with diabetes and CV risk, personalized care matters.
    Am J Manag Care. 2017;23.
    PubMed    


    November 2017
  54. MIN L, Cigolle CT, Bernstein SJ, Ward K, et al
    Diabetes care improvement in pharmacist- versus nurse-supported patient-centered medical homes.
    Am J Manag Care. 2017;23:e374-e381.
    PubMed     Abstract available


    October 2017
  55. JONES C, Mohlman MK, Jorgenson D, Finison K, et al
    Statewide data infrastructure supports population health management: diabetes case study.
    Am J Manag Care. 2017;23:e331-e339.
    PubMed     Abstract available


    August 2017
  56. MORELLO CM
    Overview of the cardiovascular benefit with diabetic agents and novel combination products for type 2 diabetes.
    Am J Manag Care. 2017;23.
    PubMed     Abstract available


  57. MORELLO CM, Hirsch JD
    Strategies for addressing the cost of nonadherence in diabetes.
    Am J Manag Care. 2017;23.
    PubMed     Abstract available


  58. HIRSCH JD, Morello CM
    Economic impact of and treatment options for type 2 diabetes.
    Am J Manag Care. 2017;23.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: